Northwest Bio closes convertible debt offering

|About: Northwest Biotherapeut... (NWBO)|By:, SA News Editor

Northwest Biotherapeutics (NWBO -2.1%) closes a $17.5M convertible note paying 5% interest for a term of three years. The notes are convertible into common stock at $7.50 per share. Investors also have three-month option to buy an additional 30% of the notes.

Proceeds will be used to fund increased manufacturing capacity and ongoing clinical trials.

NWBO shares closed today at $5.98.